Tysabri News
Timothy L. Vollmer, MD
Professor
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center
My Educational Video on MS and MS Trials
Produced by www.MSNewsChannel.com
Jennifer
Landry
News Editor
Josi
Creek
News Editor
Desinie
Smith
Senior News Editor
Patti
McArthur
News Editor
Erin
Tysabri
Editor
We Accept No Advertising
  • Founded 2004 by Stan Swartz
    •
    This site is run by Facebook Volunteers.

    Visit our Facebook Page at:

    facebook.com/StansAngels

    400,000+ Facebook & MySpace Visitors! MS News Channel Visitors:
    HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
    CLICKING ON THE RED BUTTON BELOW
    You'll get FREE Breaking News Alerts on new MS treatments as they are approved
    PLUS: We will notify you when we produce videos like the one below that we filmed with Dr. Timothy Vollmer to help you understand Tysabri's temporary withdrawal from the market
    Timothy L. Vollmer M.D.
    Department of Neurology
    University of Colorado Health Sciences Center
    Co-Director of the RMMSC at Anschutz Medical Center
    and
    Medical Director-Rocky Mountain MS Center
    OUR TERMS & CONDITIONS OF USE

    Click to view 1280 MS Walk photos!
    "MS Can Not
    Rob You of Joy"
    "I'm an M.D....my Mom has MS and we have a message for everyone."
    - Jennifer Hartmark-Hill MD
    Beverly Dean
    "I've had MS for 2 years...this is the most important advice you'll ever hear."
    "This is how I give myself a painless injection."
    Heather Johnson
    "A helpful tip for newly diagnosed MS patients."
    "Important advice on choosing MS medication "
    Joyce Moore
    Previious Posts
    MS NEWS ARCHIVES: by week

    This page is powered by Blogger. Isn't yours?

    Saturday, March 27

     

    U.S. warns of risk rise with more Tysabri infusions

    (Posted By: Josi Creek)
    February 6, 2010

    WASHINGTON (Reuters) - The risk of a potentially fatal brain disorder with Biogen Idec Inc's multiple sclerosis drug Tysabri increases as patients receive more infusions, U.S. health officials warned on Friday.

    The prescribing instructions for Tysabri will be updated to warn of the higher risk with more treatment, the Food and Drug Administration said. Elan Corp co-markets the drug.

    To read the full story, click here.



    << Home